摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

propargyl ethylene phosphate

中文名称
——
中文别名
——
英文名称
propargyl ethylene phosphate
英文别名
PEPP;2-Prop-2-ynoxy-1,3,2lambda5-dioxaphospholane 2-oxide;2-prop-2-ynoxy-1,3,2λ5-dioxaphospholane 2-oxide
propargyl ethylene phosphate化学式
CAS
——
化学式
C5H7O4P
mdl
——
分子量
162.082
InChiKey
RJKGEFYRXRRZKT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.6
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    propargyl ethylene phosphatecopper(ll) sulfate pentahydrate三氟甲磺酸sodium ascorbate 作用下, 以 四氢呋喃乙腈 为溶剂, 反应 48.0h, 生成
    参考文献:
    名称:
    Synthesis and application of moisture-stable methallylsilanated phosphorylcholine as a surface modifier
    摘要:
    New methallylsilanated phosphorylcholine (MASPCs) were synthesized via a copper-catalyzed 'click' reaction and demonstrated excellent moisture stability. Hydroxylated silicon compounds, silanol, and silica were grafted or modified by MASPCs in the presence of triflic acid (TfOH) and they possessed a good grafting efficiency and high loading rate. (C) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2014.09.076
  • 作为产物:
    参考文献:
    名称:
    改善紫杉醇递送:聚乙二醇化聚磷酸酯基纳米载体的体外和体内表征
    摘要:
    纳米材料通过在局部提供高浓度治疗剂的持续释放,特别是当给药途径允许直接进入患病组织时,具有提供针对破坏性疾病的有效治疗的巨大潜力。可生物降解的聚磷酸酯基聚合物胶束和壳交联膝状纳米粒子 (SCK) 由两亲性嵌段接枝三元共聚物 PEBP-b-PBYP-g-PEG 设计而成,可有效结合高浓度的紫杉醇 (PTX)。制备了物理负载 PTX 的分散良好的纳米粒子,表现出理想的理化特性。将 10 wt% PTX 封装到胶束或 SCK 中,允许 PTX 的水悬浮液浓度高达 4.8 mg/mL,相比之下 <2。单独药物的水溶性为 0 μg/mL。药物释放研究表明,从这些纳米结构中释放的 PTX 是通过结构-功能关系定义的,通过胶束结构的交联形成 SCK,持续释放的 PTX 的半衰期加倍。在体外,物理负载的胶束和 SCK 纳米治疗剂证明了对骨肉瘤细胞系的 IC50 值,骨肉瘤细胞系已知转移到肺(CCH-OS-O
    DOI:
    10.1021/ja512616s
点击查看最新优质反应信息

文献信息

  • 阻燃添加剂及其制备方法和应用
    申请人:恒大新能源科技集团有限公司
    公开号:CN110590848A
    公开(公告)日:2019-12-20
    本发明公开了一种阻燃添加剂及其制备方法和应用。本发明针对现有技术中含磷阻燃剂存在的诸多性能上的缺点以及制造和使用成本高的问题,提供了一种新型的含磷阻燃剂,该阻燃剂作为非水电解液二次电池电解液中的阻燃添加剂进行使用,同时提供了上述阻燃剂的制备方法。本发明中制备出的含磷阻燃剂不仅能有效提升电池安全性,而且具有特定的正负极成膜功能,可显著提升二次电池高低温、循环和存储等综合性能。本发明中所提供的阻燃剂制备方法具有原料成本低、制备工艺步骤简单、操作安全、产物纯度高、环境污染小的优势。
  • 一种1,2-丙二醇胆碱磷酸类化合物及其制备方法与应用
    申请人:于喜飞
    公开号:CN115746051A
    公开(公告)日:2023-03-07
    本发明涉及一种1,2‑丙二醇胆碱磷酸类化合物及其制备方法与应用,属于化合物合成技术领域。本发明的1,2‑丙二醇胆碱磷酸类化合物,结构式如式(I)所示。本发明的1,2‑丙二醇胆碱磷酸类化合物的制备方法简便,后处理简单,是合成胆碱磷酸脂质分子(逆磷脂)的中间体材料,使胆碱磷酸脂质分子的合成过程变得简单高效,有利于推进胆碱磷酸脂质体的产业化进程,并进一步推进脂质体类药物的快速发展。
  • Revisit to Synthesis of Allyl- and Propargyl-Phosphorylcholines: Crystal Structure of Allyl-Phosphorylcholine
    作者:Lei Liu、Myong Euy Lee、Philjae Kang、Moon-Gun Choi
    DOI:10.1080/10426507.2014.996878
    日期:2015.9.2
    Allyl- and propargyl-phosphorylcholines were efficiently synthesized and fully characterized. The molecular structure of allyl-phosphorylcholine was studied by single-crystal X-ray diffraction for the first time.
  • Synthesis and application of moisture-stable methallylsilanated phosphorylcholine as a surface modifier
    作者:Lei Liu、Jun Hyun Song、Myong Euy Lee、Ye Ri Han、Chul-Ho Jun
    DOI:10.1016/j.tetlet.2014.09.076
    日期:2014.11
    New methallylsilanated phosphorylcholine (MASPCs) were synthesized via a copper-catalyzed 'click' reaction and demonstrated excellent moisture stability. Hydroxylated silicon compounds, silanol, and silica were grafted or modified by MASPCs in the presence of triflic acid (TfOH) and they possessed a good grafting efficiency and high loading rate. (C) 2014 Elsevier Ltd. All rights reserved.
  • Improving Paclitaxel Delivery: <i>In Vitro</i> and <i>In Vivo</i> Characterization of PEGylated Polyphosphoester-Based Nanocarriers
    作者:Fuwu Zhang、Shiyi Zhang、Stephanie F. Pollack、Richen Li、Amelia M. Gonzalez、Jingwei Fan、Jiong Zou、Sarah E. Leininger、Adriana Pavía-Sanders、Rachel Johnson、Laura D. Nelson、Jeffery E. Raymond、Mahmoud Elsabahy、Dennis M. P. Hughes、Mark W. Lenox、Tiffany P. Gustafson、Karen L. Wooley
    DOI:10.1021/ja512616s
    日期:2015.2.11
    form SCKs. In vitro, physically loaded micellar and SCK nanotherapeutics demonstrated IC50 values against osteosarcoma cell lines, known to metastasize to the lungs (CCH-OS-O and SJSA), similar to the pharmaceutical Taxol formulation. Evaluation of these materials in vivo has provided an understanding of the effects of nanoparticle structure-function relationships on intratracheal delivery and related
    纳米材料通过在局部提供高浓度治疗剂的持续释放,特别是当给药途径允许直接进入患病组织时,具有提供针对破坏性疾病的有效治疗的巨大潜力。可生物降解的聚磷酸酯基聚合物胶束和壳交联膝状纳米粒子 (SCK) 由两亲性嵌段接枝三元共聚物 PEBP-b-PBYP-g-PEG 设计而成,可有效结合高浓度的紫杉醇 (PTX)。制备了物理负载 PTX 的分散良好的纳米粒子,表现出理想的理化特性。将 10 wt% PTX 封装到胶束或 SCK 中,允许 PTX 的水悬浮液浓度高达 4.8 mg/mL,相比之下 <2。单独药物的水溶性为 0 μg/mL。药物释放研究表明,从这些纳米结构中释放的 PTX 是通过结构-功能关系定义的,通过胶束结构的交联形成 SCK,持续释放的 PTX 的半衰期加倍。在体外,物理负载的胶束和 SCK 纳米治疗剂证明了对骨肉瘤细胞系的 IC50 值,骨肉瘤细胞系已知转移到肺(CCH-OS-O
查看更多

同类化合物

尿苷5'-二磷酸酯溴乙酰醇 N,N-二乙基-4-甲基-1,3,2-二氧杂磷杂环戊烷-2-胺 4,4,5,5-四甲基-1,3,2-二氧磷杂环戊烷-2-醇 2-氯-4-甲基-1,3,2-二氧杂磷杂环戊烷 2-氯-4,4,5,5-四甲基-1,3,2-二氧磷杂环戊烷 2-氯-1,3,2-二氧磷杂环戊烷 (3,5-二甲基苯基)[羟基(吡啶-4-基甲基)-lambda~5~-氮烷基]甲酮 2-(2-ethylbutoxy)-2-oxo-1,3,2-dioxaphospholane 2-(tert-butoxycarbonylamino)ethoxy-2-oxo-1,3,2-dioxaphospholane 5-dimethylamino-7-isopropylidene-8,8-dimethyl-1,4,6-trioxa-5λ5-phospha-spiro[4.4]nonan-9-one 5-dipropylaminomethyl-1,4,6,9-tetraoxa-5-phosphaspiro<4.4>nonane ethylenedioxy-O-(4,4-dimethyl-1,3-butadien-2-yl)phosphite pentamethyl-2,3,3,4,4 dioxaphospholane-1,3,2 propargyl ethylene phosphate 2-methylthio-4,4,5,5-tetrakis(trifluoromethyl)-1,3,2λ5-dioxaphospholane 2,2-bis(diethylamino)-2-(1,1,1,3,3,3-hexafluoro)isopropoxy-4,4,5,5-tetrakis(trifluoromethyl)-1,3,2λ5ς5-dioxaphospholane 4,4,5,5-tetrakis(trifluoromethyl)-2-<2,2,2-trifluoro-1-(trifluoromethyl)ethoxy>-spiro-<1,3,2λ5-dioxaphospholane-2,2'-(1,3,2λ5) dioxaphosphorinane> 4-chloromethyl-[1,3,2]dioxaphospholane 2-oxide 5-Methoxy-2,2,3,3-tetramethyl-7,9-bis(trifluoromethyl)-1,4,6-trioxa-5lambda5-phosphaspiro[4.4]non-7-en-9-ol 2,2-Dimethoxy-2-methyl-4,4,5,5-tetrakis(trifluoromethyl)-1,3,2lambda5-dioxaphospholane 5,7-Dimethyl-2,2,3,3,9,9,10,10-octakis(trifluoromethyl)-1,4,6,8,11-pentaoxa-5lambda5,7lambda5-diphosphadispiro[4.1.47.35]tetradecane Butylamino-ethylendioxyphosphin 5-Dichloromethyl-1,4,6,9-tetraoxa-5λ5-phospha-spiro[4.4]nonane-2,7-dione 5-Fluoro-1,4,6,9-tetraoxa-5λ5-phospha-spiro[4.4]nonane-2,7-dione Ethylendioxytributylphosphoran 2-Thiono-2-t-butyl-1,3,2-dioxaphospholan (5-TB-5-13;5'-TB-5-13)-2,2,3,3,2',2',3',3'-octamethyl-5,5'-ethane-1,2-diyldioxy-bis-(1,4,6,9-tetraoxa-5λ5-phospha-spiro[4.4]nonane) (1,4-Dioxa-6,9-dithia-5λ5-phospha-spiro[4.4]non-5-yl)-dimethyl-amine 5-Trimethylsilanylmethyl-1,4,6,9-tetraoxa-5λ5-phospha-spiro[4.4]nonane-2,7-dione 5-Isopropyl-1,4,6,9-tetraoxa-5λ5-phospha-spiro[4.4]nonane-2,7-dione 5-(2,2,2-Trifluoro-1-trifluoromethyl-ethoxy)-1,4,6,9-tetraoxa-5λ5-phospha-spiro[4.4]nonane 2,2,2-Tris-(2,2,2-trifluoro-1-trifluoromethyl-ethoxy)-2λ5-[1,3,2]dioxaphospholane 2,2,2-trichloro-4,4-bis-chlorocarbonylmethyl-2λ5-[1,3,2]dioxaphospholan-5-one 5,6,7,12-Tetramethyl-2,2,3,3,9,9,10,10-octakis-trifluoromethyl-1,4,8,11-tetraoxa-6,12-diaza-5λ5,7λ5-diphospha-dispiro[4.1.4.1]dodecane 2,2-Difluoro-4,4,5,5-tetrakis-trifluoromethyl-2λ5-[1,3,2]dioxaphospholane 2-Fluoro-4,4,5,5-tetrakis-trifluoromethyl-2λ5-[1,3,2]dioxaphospholane (2-TB-5-12)-2-fluoro-4,4,5,5-tetrakis-trifluoromethyl-2,2-bis-(2,2,2-trifluoro-1-trifluoromethyl-ethoxy)-2λ5-[1,3,2]dioxaphospholane Triethoxy-ethylendioxy-phosphoran 4,4,5,5-Tetrakis(trifluormethyl)-1,3,2λ5-dioxaphospholan-2,2,2-triamin 2-fluoro-4,4,5,5-tetrakis(trifluoromethyl)-1,3,2λ5-dioxaphospholane-2,2-diamine 2-Fluor-4,4,5,5-tetrakis-(trifluormethyl)-(1,3,2λ5-dioxaphospholan 5,7-difluoro-2,2,3,3,9,9,10,10-octakis-trifluoromethyl-6,12-bis-trimethylsilanyl-1,4,8,11-tetraoxa-6,12-diaza-5λ5,7λ5-diphospha-dispiro[4.1.4.1]dodecane [2-(1,1,1,3,3,3-hexamethyl-disilazan-2-yl)-4,4,5,5-tetrakis-trifluoromethyl-2λ5-[1,3,2]dioxaphospholan-2-ylidene]-trimethylsilanyl-amine 2,2-Di-tert-Butyl-2-chlor-4,4,5,5-tetrakis(trifluormethyl)-1,3,2λ5-dioxaphospholan 2-fluoro-2,2-dimethyl-4,4,5,5-tetrakis-trifluoromethyl-2λ5-[1,3,2]dioxaphospholane 2-fluoro-2,2-dimethyl-3,3,5,5-tetrakis-trifluoromethyl-2λ5-[1,4,2]dioxaphospholane 2-diethylamino-2,2-difluoro-4,4,5,5-tetrakis-trifluoromethyl-2λ5-[1,3,2]dioxaphospholane 2-diallylamino-2,2-difluoro-4,4,5,5-tetrakis-trifluoromethyl-2λ5-[1,3,2]dioxaphospholane 2-Methyl-4,4,5,5-tetrakis-trifluoromethyl-2,2-bis-(2,2,2-trifluoro-1-trifluoromethyl-ethoxy)-2λ5-[1,3,2]dioxaphospholane